1. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
3. |
Ashhab AA, Rodin H, Powell J, et al. Hepatocellular carcinoma diagnosis and surveillance: Socioeconomic factors don’t seem to matter, unless you are an immigrant. J Hepatol, 2017, 67(3): 648-649.
|
4. |
Petruzziello A, Marigliano S, Loquercio G, et al. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol, 2016, 22(34): 7824-7840.
|
5. |
孙厚芳, 颜次慧, 吴磊, 等. 基于生物信息学分析的肝细胞癌预后相关基因的筛选. 中国肿瘤生物治疗杂志, 2019, 26(4): 431-439.
|
6. |
Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol, 2016, 1418: 93-110.
|
7. |
Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS, 2012, 16(5): 284-287.
|
8. |
Powers RK, Goodspeed A, Pielke-Lombardo H, et al. GSEA-InContext: identifying novel and common patterns in expression experiments. Bioinformatics, 2018, 34(13): i555-i564.
|
9. |
Feng Z, Qiao R, Ren Z, et al. Could CTSK and COL4A2 be specific biomarkers of poor prognosis for patients with gastric cancer in Asia?—a microarray analysis based on regional population. J Gastrointest Oncol, 2020, 11(2): 386-401.
|
10. |
Mancebo A, González-Diéguez ML, Cadahía V, et al. Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups. Clin Gastroenterol Hepatol, 2013, 11(1): 95-101.
|
11. |
Tian J, Hu X, Gao W, et al. Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma. Am J Transl Res, 2016, 8(6): 2575-2584.
|
12. |
Meng Z, Chen Y, Lu M. Advances in targeting the innate and adaptive immune systems to cure chronic hepatitis B virus infection. Front Immunol, 2020, 10: 3127.
|
13. |
张源净, 杭小锋, 王俊学. 乙型肝炎病毒基因整合与相关肝病的研究进展. 中华传染病杂志, 2020, 38(2): 125-128.
|
14. |
Feitelson MA, Bonamassa B, Arzumanyan A. The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease. Expert Opin Ther Targets, 2014, 18(3): 293-306.
|
15. |
Samreen B, Khaliq S, Ashfaq UA, et al. Hepatitis C virus entry: role of host and viral factors. Infect Genet Evol, 2012, 12(8): 1699-1709.
|
16. |
Ray RB, Ray R. Hepatitis C virus manipulates humans as its favorite host for a long-term relationship. Hepatology, 2019, 69(2): 889-900.
|
17. |
Petruzziello A, Marigliano S, Loquercio G, et al. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe. Infect Agent Cancer, 2016, 11: 53.
|
18. |
Mahale P, Torres HA, Kramer JR, et al. Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study. Cancer, 2017, 123(7): 1202-1211.
|
19. |
Petruzziello A. Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma. Open Virol J, 2018, 12: 26-32.
|
20. |
Zampino R, Marrone A, Restivo L, et al. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol, 2013, 5(10): 528-540.
|
21. |
Estevez J, Chen VL, Podlaha O, et al. Differential serum cytokine profiles in patients with chronic hepatitis B, C, and hepatocellular carcinoma. Sci Rep, 2017, 7(1): 11867.
|
22. |
Banaganapalli B, Mansour H, Mohammed A, et al. Exploring celiac disease candidate pathways by global gene expression profiling and gene network cluster analysis. Sci Rep, 2020, 10(1): 16290.
|
23. |
Lin JP, Fan YK, Liu HM. The 14-3-3η chaperone protein promotes antiviral innate immunity via facilitating MDA5 oligomerization and intracellular redistribution. PLoS Pathog, 2019, 15(2): e1007582.
|